At a glance
- Originator National Cancer Institute (USA)
- Class Antineoplastics; Aziridines; Benzoquinones; Small molecules
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 25 Jan 2001 No-Development-Reported for Cancer in USA (Unknown route)